Table 1.

Clinical characteristics, ICU therapies and outcomes

Characteristic	Patients (N = 18)
Median age (IQR) (years)	67 (60–73)
Sex, n (%)
Male	14 (78)
Female	4 (22)
ICU therapy†, n/N (%)
High‐flow nasal oxygen	14/18 (78)
Non‐invasive ventilation	0/18
Invasive mechanical ventilation	8/18 (44)
Prone positioning	5/8 (63)
Extracorporeal membrane oxygenation	0/18
Vasoactive therapy	11/18 (61)
Continuous renal‐replacement therapy	4/18 (22)
Outcomes‡
Median length of stay (IQR) (days)
In hospital	13 (11–17)
In ICU	4 (2–14)
In hospital, survivors	13 (10–25)
In ICU, survivors	3(2–14)
Median duration of mechanical ventilation (IQR), (days)	11 (8–13)
Extubation, n/N (%)	3/8 (38%)
Died in ICU, n (%)	4 (22)
Discharged from ICU, n (%)	13 (72)

^† Therapies received at any time during the index ICU admission. High‐flow nasal cannula was used with a maximum of 30 L/min flow.

^‡ Based on a censor date of 23 April 2020. ICU, intensive care unit.